IEC Symposium at 2017 SID Annual Meeting - Oregon Convention Center, Portland OR
Friday, April 28, 2017
Category: IEC Events (for everyone)

Oregon Convention Center – Oregon Ballroom 204

Please join the IEC for a special session on Atopic Dermatitis research at the Society for Investigative Dermatology 2017 Annual Meeting with featured speaker, Dr. Masa Amagai, as well as IEC’s roadmap of AD Research for the 2017 SID meeting and presentations for various abstracts.


Noon-12:10 pm
Welcome/Overview of the IEC and Roadmap of AD at the SID
Amy Paller, MD, IEC President, Northwestern University, Chicago, IL, USA

12:10-12:45 pm
Abstract Presentations

#256 Increased interleukin-19 expression in cutaneous T-cell lymphoma as well as atopic dermatitis. Oka Tomonori et al. Univ. of Tokyo, Tokyo, Japan

#623 Cutaneous acquisition of Staphylococcus quorum-sensing agr mutations protects against atopic dermatitis development. Yuumi Nakamura et al., Chiba Univ., Chiba, Japan

#642 The serum proteomic signature of pediatric AD suggests early Th2/Th17 skewing and an inverse correlation of disease severity with Th1 markers. Patrick Brunner et al. Rockefeller Univ., New York, NY, USA

12:45-1:05 pm
Special Presentation: The precise control of skin barrier homeostasis Masayuki Amagai, Keio University, Tokyo, Japan

1:10-1:30 pm
Abstract Presentations

#296 Bleach baths promote early induction of inflammatory pathway genes with no effect on skin bacterial dysbiosis in AD subjects. Sara Knowlden et al., Univ. of Rochester, Rochester, NY, USA

#251 Treatment interruption did not impact efficacy or long-term safety of dupilumab: A phase 3 open-label trial. Lisa Beck et al. Univ. of Rochester, Rochester, NY, USA

Click here to view the Roadmap of AD at the SID